| Post |
| Pre |
| LA |
|---|
| 1 |
| - |
| ME 1 | ME 2 | ME 3 | ME 4 | ME 5 | ME 6 | ME 7 | ME 8 | ME 9 | ME 10 | Total |
|---|---|---|---|---|---|---|---|---|---|---|
| - | - | 1 | - | - | - | - | - | - | - | - |
| - | - | - | - | - | - | - | - | - | - | - |
| Post |
| Pre |
| LO 1 | LO 2 | LO 3 | LO 4 | LO 5A | LO 5B | LO 6 | Total |
|---|---|---|---|---|---|---|---|
| - | - | - | - | - | 15 | 969 | 984 |
| - | - | - | - | - | - | 21 | 21 |
| AME |
|---|
| 2 |
| - |
| Post |
| Pre |
| LOP 1 | LOP 2 | LOP 3 | LOP 4 | Total |
|---|---|---|---|---|
| - | - | - | - | - |
| - | - | - | - | - |
| central brain |
|---|
| 35 |
| 3 |

| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| LO(L) | 984 | 81.3% | -5.55 | 21 | 52.5% |
| Optic-unspecified(L) | 188 | 15.5% | -3.55 | 16 | 40.0% |
| PLP(L) | 22 | 1.8% | -inf | 0 | 0.0% |
| CentralBrain-unspecified | 13 | 1.1% | -2.12 | 3 | 7.5% |
| AME(L) | 2 | 0.2% | -inf | 0 | 0.0% |
| LA(L) | 1 | 0.1% | -inf | 0 | 0.0% |
| ME(L) | 1 | 0.1% | -inf | 0 | 0.0% |
| upstream partner | # | NT | conns Lat5 | % In | CV |
|---|---|---|---|---|---|
| LC40 (L) | 16 | ACh | 276 | 24.6% | 0.8 |
| Tm31 (L) | 29 | GABA | 127 | 11.3% | 0.7 |
| Tm16 (L) | 43 | ACh | 110 | 9.8% | 0.7 |
| LoVP13 (L) | 13 | Glu | 92 | 8.2% | 0.6 |
| LC41 (L) | 6 | ACh | 58 | 5.2% | 1.1 |
| Li35 (L) | 13 | GABA | 55 | 4.9% | 0.8 |
| Li14 (L) | 26 | Glu | 51 | 4.5% | 0.6 |
| Tm38 (L) | 16 | ACh | 33 | 2.9% | 0.7 |
| LC10e (L) | 14 | ACh | 33 | 2.9% | 0.5 |
| MeLo1 (L) | 12 | ACh | 23 | 2.0% | 0.6 |
| LoVP14 (L) | 7 | ACh | 17 | 1.5% | 0.6 |
| LT55 (L) | 1 | Glu | 15 | 1.3% | 0.0 |
| LC37 (L) | 4 | Glu | 13 | 1.2% | 0.3 |
| LT52 (L) | 4 | Glu | 12 | 1.1% | 1.0 |
| TmY17 (L) | 6 | ACh | 12 | 1.1% | 0.6 |
| LT46 (R) | 1 | GABA | 10 | 0.9% | 0.0 |
| LoVC4 (L) | 1 | GABA | 10 | 0.9% | 0.0 |
| LC20a (L) | 6 | ACh | 9 | 0.8% | 0.5 |
| TmY13 (L) | 3 | ACh | 8 | 0.7% | 0.4 |
| Tm34 (L) | 6 | Glu | 8 | 0.7% | 0.4 |
| LoVC22 (R) | 2 | DA | 7 | 0.6% | 0.1 |
| LoVCLo2 (L) | 1 | unc | 6 | 0.5% | 0.0 |
| MeLo2 (L) | 6 | ACh | 6 | 0.5% | 0.0 |
| LoVC9 (R) | 1 | GABA | 5 | 0.4% | 0.0 |
| MeTu4f (L) | 4 | ACh | 5 | 0.4% | 0.3 |
| MeLo7 (L) | 5 | ACh | 5 | 0.4% | 0.0 |
| aMe3 (L) | 1 | Glu | 4 | 0.4% | 0.0 |
| LC14a-2 (R) | 2 | ACh | 4 | 0.4% | 0.5 |
| LC27 (L) | 3 | ACh | 4 | 0.4% | 0.4 |
| TmY10 (L) | 3 | ACh | 4 | 0.4% | 0.4 |
| DNp27 (L) | 1 | ACh | 3 | 0.3% | 0.0 |
| LoVP29 (L) | 1 | GABA | 3 | 0.3% | 0.0 |
| Li20 (L) | 1 | Glu | 3 | 0.3% | 0.0 |
| LoVP17 (L) | 1 | ACh | 3 | 0.3% | 0.0 |
| DNpe053 (R) | 1 | ACh | 3 | 0.3% | 0.0 |
| aMe13 (L) | 1 | ACh | 3 | 0.3% | 0.0 |
| MeVPMe11 (R) | 1 | Glu | 3 | 0.3% | 0.0 |
| LoVCLo3 (R) | 1 | OA | 3 | 0.3% | 0.0 |
| DNp27 (R) | 1 | ACh | 3 | 0.3% | 0.0 |
| LoVP7 (L) | 2 | Glu | 3 | 0.3% | 0.3 |
| Li34a (L) | 2 | GABA | 3 | 0.3% | 0.3 |
| Li13 (L) | 2 | GABA | 3 | 0.3% | 0.3 |
| Tm37 (L) | 3 | Glu | 3 | 0.3% | 0.0 |
| aMe6a (L) | 1 | ACh | 2 | 0.2% | 0.0 |
| Li27 (L) | 1 | GABA | 2 | 0.2% | 0.0 |
| Li18a (L) | 1 | GABA | 2 | 0.2% | 0.0 |
| LC14b (R) | 1 | ACh | 2 | 0.2% | 0.0 |
| LT72 (L) | 1 | ACh | 2 | 0.2% | 0.0 |
| LPT51 (L) | 1 | Glu | 2 | 0.2% | 0.0 |
| LoVP96 (L) | 1 | Glu | 2 | 0.2% | 0.0 |
| Li36 (L) | 1 | Glu | 2 | 0.2% | 0.0 |
| LoVC18 (L) | 1 | DA | 2 | 0.2% | 0.0 |
| MeVP3 (L) | 2 | ACh | 2 | 0.2% | 0.0 |
| Tm36 (L) | 2 | ACh | 2 | 0.2% | 0.0 |
| Li21 (L) | 2 | ACh | 2 | 0.2% | 0.0 |
| MeVC20 (L) | 2 | Glu | 2 | 0.2% | 0.0 |
| LoVP5 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| LT59 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| PLP131 (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| LC15 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| aMe6b (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| Tm5Y (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| Y3 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| LoVP52 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| LC21 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| LC28 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| MeTu4d (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| PLP185 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| LHPV2i2_b (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| LoVP33 (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| Li34b (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| LC46b (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| LT63 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| Li19 (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| MeLo3a (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| CL356 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| Lat4 (L) | 1 | unc | 1 | 0.1% | 0.0 |
| aMe30 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| LoVP46 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| LoVP107 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| MeVP27 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| MeVC21 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| MeVPaMe2 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| LoVCLo2 (R) | 1 | unc | 1 | 0.1% | 0.0 |
| LoVP45 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| Li39 (R) | 1 | GABA | 1 | 0.1% | 0.0 |
| LoVCLo3 (L) | 1 | OA | 1 | 0.1% | 0.0 |
| LT39 (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| OLVC5 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| DNpe053 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| LoVC12 (R) | 1 | GABA | 1 | 0.1% | 0.0 |
| mALD1 (R) | 1 | GABA | 1 | 0.1% | 0.0 |
| 5-HTPMPV03 (R) | 1 | 5-HT | 1 | 0.1% | 0.0 |
| downstream partner | # | NT | conns Lat5 | % Out | CV |
|---|---|---|---|---|---|
| LT51 (L) | 5 | Glu | 15 | 22.1% | 0.6 |
| LC36 (L) | 2 | ACh | 7 | 10.3% | 0.4 |
| LoVP17 (L) | 1 | ACh | 4 | 5.9% | 0.0 |
| LC19 (L) | 1 | ACh | 3 | 4.4% | 0.0 |
| LC10b (L) | 1 | ACh | 3 | 4.4% | 0.0 |
| LoVP90a (L) | 1 | ACh | 3 | 4.4% | 0.0 |
| LC46b (L) | 2 | ACh | 3 | 4.4% | 0.3 |
| TmY17 (L) | 1 | ACh | 2 | 2.9% | 0.0 |
| LPLC2 (L) | 1 | ACh | 2 | 2.9% | 0.0 |
| LC13 (L) | 2 | ACh | 2 | 2.9% | 0.0 |
| Tm38 (L) | 1 | ACh | 1 | 1.5% | 0.0 |
| LOLP1 (L) | 1 | GABA | 1 | 1.5% | 0.0 |
| MeLo1 (L) | 1 | ACh | 1 | 1.5% | 0.0 |
| Li13 (L) | 1 | GABA | 1 | 1.5% | 0.0 |
| Li14 (L) | 1 | Glu | 1 | 1.5% | 0.0 |
| Li19 (L) | 1 | GABA | 1 | 1.5% | 0.0 |
| LT86 (L) | 1 | ACh | 1 | 1.5% | 0.0 |
| LC21 (L) | 1 | ACh | 1 | 1.5% | 0.0 |
| LC27 (L) | 1 | ACh | 1 | 1.5% | 0.0 |
| LC41 (L) | 1 | ACh | 1 | 1.5% | 0.0 |
| LC11 (L) | 1 | ACh | 1 | 1.5% | 0.0 |
| Li21 (L) | 1 | ACh | 1 | 1.5% | 0.0 |
| LC10d (L) | 1 | ACh | 1 | 1.5% | 0.0 |
| Y14 (L) | 1 | Glu | 1 | 1.5% | 0.0 |
| Tm16 (L) | 1 | ACh | 1 | 1.5% | 0.0 |
| LC6 (L) | 1 | ACh | 1 | 1.5% | 0.0 |
| MeVP31 (L) | 1 | ACh | 1 | 1.5% | 0.0 |
| LT64 (L) | 1 | ACh | 1 | 1.5% | 0.0 |
| LC40 (L) | 1 | ACh | 1 | 1.5% | 0.0 |
| LC10c-2 (L) | 1 | ACh | 1 | 1.5% | 0.0 |
| Lat4 (L) | 1 | unc | 1 | 1.5% | 0.0 |
| aMe12 (L) | 1 | ACh | 1 | 1.5% | 0.0 |
| LoVP90c (L) | 1 | ACh | 1 | 1.5% | 0.0 |
| Li39 (R) | 1 | GABA | 1 | 1.5% | 0.0 |